42
Participants
Start Date
November 14, 2013
Primary Completion Date
January 9, 2015
Study Completion Date
January 9, 2015
teduglutide
Open label intervention. Each subject will be assigned to receive 0.0125, 0.025, or 0.05 mg/kg/day for the duration of the study
Montefiore Medical Center, The Bronx
Arnold Palmer Hospital for Children, Orlando
Children´s Hospital of Alabama, Birmingham
Monroe Carell, Jr. Children's Hospital at Vanderbilt, Nashville
University of Tennessee Health Science Center Le Bonheur Pediatric Specialists, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children at IU Health, Indianapolis
Mott Children's Hospital, University of Michigan, Ann Arbor
University of Wisconsin School of Medicine and Public Health Surgery, Madison
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Childrens Mercy Hospitals & Clinics Pediatric Gastroenterology, Kansas City
University of Nebraska Medical Center, Omaha
Arkansas Children's Hospital, Little Rock
Texas Children's Hospital, Baylor College of Medicine, Houston
Children's Hospital Los Angeles, Los Angeles
Mattel Children's Hospital UCLA, Department of Pediatric Gastroenterology, Los Angeles
Seattle Childrens Hospital Gastroenterology and Hepatology, Seattle
Boston Children's Hospital, Boston
Great Ormond Street Hospital for Children, London
Lead Sponsor
Shire
INDUSTRY